Day: January 13, 2023

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting   Trial Data Shows InFoods® IBS Treatment Diet Significantly Improved Several IBS Symptoms Including Abdominal Pain Intensity (API): In Some Cases Better Than Certain Currently Marketed Drugs   Launch of InFoods® IBS Lab Developed Test Expected in Fiscal 3Q   Amazon Now Fulfills Sales of Aware® Breast Self Exam and EZ Detect™ Colon Disease Tests IRVINE, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) — IRVINE, CABiomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its second quarter fiscal 2023 financial results for the period ended November 30, 2022. Net sales for the three months ended November 30, 2022 were $1.5 million as compared...

Continue reading

Repurchase Offer and Stub Repurchase Offer IN RESPECT OF  DCAC Shareholders (ISIN Code GG00BMB5XZ39) and DCAC Public Warrant Holders (ISIN Code GG00BMB5XY22)

Repurchase Offer and Stub Repurchase Offer IN RESPECT OF DCAC Shareholders (ISIN Code GG00BMB5XZ39) and DCAC Public Warrant Holders (ISIN Code GG00BMB5XY22)

DISRUPTIVE CAPITAL ACQUISITION COMPANY LIMITED(“DCAC” or the “Company”)Repurchase Offer and Stub Repurchase OfferIN RESPECT OF DCAC Shareholders (ISIN Code GG00BMB5XZ39) andDCAC Public Warrant Holders (ISIN Code GG00BMB5XY22)13 January 2023 THIS PRESS RELEASE CONTAINS INFORMATION THAT QUALIFIES OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EU MARKET ABUSE REGULATION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS Background Following release of a circular and notice of meetings to...

Continue reading

CenterPoint Energy, Inc. to Host Webcast of Fourth Quarter 2022 Earnings Conference Call

CenterPoint Energy, Inc. to Host Webcast of Fourth Quarter 2022 Earnings Conference Call

Houston, TX, Jan. 13, 2023 (GLOBE NEWSWIRE) —   Date:  February 17, 2023 Time:  7:00 a.m. Central time or 8:00 a.m. Eastern time Listen via internet:  http://investors.centerpointenergy.com/ Click “Investors”, and click the link “CenterPoint Energy, Inc. Fourth Quarter 2022 Earnings Conference Call” As the only investor-owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) ) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Louisiana, Minnesota, Mississippi, Ohio and Texas. As of September 30 2022, the company owned approximately $35 billion in assets. With approximately 8,900 employees, CenterPoint Energy and its predecessor...

Continue reading

<div>Peyto Exploration & Development Corp. Confirms Monthly Dividend for February 15, 2023</div>

Peyto Exploration & Development Corp. Confirms Monthly Dividend for February 15, 2023

CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to January 2023 of $0.11 per common share is to be paid on February 15, 2023, for shareholders of record on January 31, 2023. The ex-dividend date for the January dividend is January 30, 2023. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the CEO and includes estimates of monthly capital expenditures and production. For further information...

Continue reading

Kimball International, Inc. to Announce Second Quarter Fiscal Year 2023 Financial Results

Kimball International, Inc. to Announce Second Quarter Fiscal Year 2023 Financial Results

JASPER, Ind., Jan. 13, 2023 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) will announce its second quarter fiscal year 2023 financial results on Thursday, February 2, 2023, after the close of the market. The Company will host a conference call on Thursday, February 2, 2023, at 5:00 p.m. ET to review its financial performance. To join the call, dial 1-833-535-2198 or internationally 1-412-317-0667 approximately ten minutes prior and tell the operator you wish to join Kimball International’s conference call.  The live webcast can be accessed at www.ir.kimballinternational.com. For those unable to participate in the live event, the call will be archived at www.ir.kimballinternational.com. About Kimball International, Inc. Kimball International is a leading omnichannel commercial furnishings company with deep expertise...

Continue reading

CFC To Host Conference Call on Fiscal Year 2023 Second-Quarter Financial Results

CFC To Host Conference Call on Fiscal Year 2023 Second-Quarter Financial Results

DULLES, Va., Jan. 13, 2023 (GLOBE NEWSWIRE) — The National Rural Utilities Cooperative Finance Corporation (CFC) will hold an investor conference call and webcast on Wednesday, January 18, at 11 a.m. Eastern Time. CFC CEO Andrew Don will provide a business update and CFC Senior Vice President and CFO Ling Wang will review CFC’s fiscal year 2023 second-quarter financial results. There are two ways to access the event: •   Live Webcast Option     Visit CFC’s investor Webcasts & Presentations page to join the webcast.     Pre-registration is available for the event.       •   Conference Call Option     Domestic: 888-394-8218 | International: 323-701-0225     Participant Code: 2903302     Callers also can view a PDF of the slide presentation by visiting the Webcasts & Presentations page on the day of the call....

Continue reading

United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone

United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone

The patent covers Nurexone’s ExoPTEN drug compositions and treatment methods for Central Nervous System disease HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with traumatic spinal cord injuries, has received a notice of allowance from the United States Patent and Trademark Office (“USPTO”) for U.S. Patent Application NO. 17/042,441 (“the Patent”). The Patent covers and protects NurExone Exo-PTEN technology, and its drug composition as well as methods for non-invasive intranasal administration of exosome-based treatment. The Patent discloses and claims groundbreaking inventions and methods in exosome technology, such as the pharmaceutical...

Continue reading

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2022

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2022

Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2022 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (January 13, 2023 – 7:30 pm) – As of December 31, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.   December 31, 2022 Shares outstanding           447,688,2331 Number of real voting rights (excluding treasury shares) 445,327,583 Theoretical number of voting rights (including treasury shares) 447,688,233 It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with...

Continue reading

True Velocity to Display Next Gen Ammunition, Firearms at 2023 SHOT Show

True Velocity to Display Next Gen Ammunition, Firearms at 2023 SHOT Show

GARLAND, Texas, Jan. 13, 2023 (GLOBE NEWSWIRE) —  Texas-based advanced defense technology company TV Ammo, Inc. (“True Velocity”), will be at booth #13454 from January 17 – 20 at SHOT Show 2023 hosted at the Venetian Expo and Caesars Forum in Las Vegas, Nevada. The appearance follows True Velocity’s recent announcement of a multi-year strategic partnership with industry-leading retailers Bass Pro Shops and Cabela’s. “We look forward every year to joining our industry colleagues at SHOT Show,” said Kevin Boscamp, Chairman and Co-CEO of True Velocity, “and this year is no different. We’re excited to show the world how True Velocity’s culture of innovation continues to result in disruptive, next-generation ammunition and weapons.” Products On Display: MILITARY AMMUNITION: 7.62x51mm NATO; 5.56x45mm NATO; .338, 50 BMG COMMERCIAL...

Continue reading

Nasdaq Halts Relativity Acquisition Corp.

Nasdaq Halts Relativity Acquisition Corp.

NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that the trading halt status in Relativity Acquisition Corp. (Nasdaq: RACY, RACYU and RACYW) was changed to “additional information requested” from the company. Trading in the company’s securities had been halted on January 11, 2023 at 17:14:36 Eastern Time for “news dissemination” at last sale prices of $12.28 (Nasdaq: RACY), $12.99 (Nasdaq: RACYU), $0.0471 (Nasdaq: RACYW). Trading will remain halted until Relativity Acquisition Corp.has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.